ACA
Avoro Capital Advisors’s Krystal Biotech KRYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366M | Sell |
2,660,000
-71,000
| -3% | -$9.76M | 6.4% | 5 |
|
|
2025
Q1 | $492M | Buy |
2,731,000
+102,178
| +4% | +$18.4M | 7.69% | 5 |
|
|
2024
Q4 | $412M | Buy |
2,628,822
+6,600
| +0.3% | +$1.03M | 5.83% | 5 |
|
|
2024
Q3 | $477M | Buy |
2,622,222
+189,222
| +8% | +$34.4M | 6.96% | 4 |
|
|
2024
Q2 | $447M | Sell |
2,433,000
-122,555
| -5% | -$22.5M | 5.95% | 6 |
|
|
2024
Q1 | $455M | Sell |
2,555,555
-10,000
| -0.4% | -$1.78M | 5.3% | 7 |
|
|
2023
Q4 | $318M | Hold |
2,565,555
| – | – | 4.4% | 11 |
|
|
2023
Q3 | $298M | Buy |
2,565,555
+4,744
| +0.2% | +$550K | 4.64% | 10 |
|
|
2023
Q2 | $301M | Buy |
2,560,811
+810,811
| +46% | +$95.2M | 4.08% | 12 |
|
|
2023
Q1 | $140M | Buy |
1,750,000
+340,000
| +24% | +$27.2M | 2.08% | 15 |
|
|
2022
Q4 | $112M | Buy |
1,410,000
+135,000
| +11% | +$10.7M | 1.67% | 15 |
|
|
2022
Q3 | $88.9M | Buy |
1,275,000
+200,000
| +19% | +$13.9M | 1.64% | 16 |
|
|
2022
Q2 | $70.6M | Buy |
1,075,000
+70,000
| +7% | +$4.6M | 1.39% | 16 |
|
|
2022
Q1 | $66.9M | Buy |
1,005,000
+530,000
| +112% | +$35.3M | 1.22% | 18 |
|
|
2021
Q4 | $33.2M | Buy |
+475,000
| New | +$33.2M | 0.57% | 30 |
|